April 3, 2013

Cover Story

CEO of the Year

Utah’s business landscape is rich with professionals who have le...Read More

Featured Articles

Did you go Skiing this winter?

Around Utah

Sections

Spotlight
Martin Plaehn

Spotlight
Karen Sendelback

Legal Briefs
Social Media and Employers: Friends or Enemies?

Money Talk
The Case for HSAs

Economic Insight
Time to Show Up

Lessons Learned
Make a Move

TechKnowledge
In the Lab

EntrepreneurEdge
Rent to Own

Business Trends
Back from the Dead

Living Well
Artful Inspiration

Features
A Breath of Fresh Air

Features
Worst-Case Scenario

Regional Report
Northern Utah

Focus
Measure Up

Industry Outlook
Travel & Tourism

Players
Players

Article

Predictive Biosciences Partners with ARUP Laboratories

Press Release

April 3, 2013

www.predictivebiosci.com%2F&esheet=50600852&lan=en-US&anchor=Predictive+Biosciences&index=1&md5=43febb8dbe397c248bb7ac6a239dcf66">Predictive Biosciences today announced a partnership withwww.aruplab.com&esheet=50600852&lan=en-US&anchor=ARUP+Laboratories&index=2&md5=90213de32db83b7197597eb08c532704"> ARUP Laboratories, a national reference laboratory and enterprise of the University of Utah, to offer the company’s molecular diagnostic bladder cancer tests to ARUP’s national network of clients.

Through a non-exclusive agreement, ARUP will offer Predictive’s CertNDx Bladder Cancer Assays in its comprehensive test menu to leading hospitals, healthcare providers, academic medical centers and military and government facilities around the country. ARUP’s clients will be able to order CertNDx testing, submit samples and receive all results through ARUP. Predictive Biosciences will run the diagnostic testing in its CAP and CLIA-certified laboratory.

“We are excited to begin our partnership with ARUP, a laboratory that shares our passion for innovation and technology,” said Pierre Cassigneul, chief executive officer at Predictive Biosciences. “We believe this alliance will greatly expand the availability of our bladder cancer products to a wider network of leading medical facilities that can benefit from CertNDx testing.”

The CertNDx Bladder Cancer Assay is a non-invasive, urine-based test to assess patients with hematuria and to monitor for bladder cancer recurrence after treatment. The test’s stratifies patients based on their likelihood of bladder cancer and is highly accurate across all stages and grades of bladder cancer. CertNDx testing is also available in a tissue-based prognostic test for molecular grading that can provide a quantitative molecular assessment of tumor grade including the likelihood of disease progression.

Utah Business Social
UB Events View All
PR Spring ConferenceUtah Business Event
May 7, 2015
Join your Utah colleagues from Utah Business along with PRSA & IABC for this important, 1-day eve...
30 Women to WatchUtah Business Event
May 21, 2015
Utah Business Magazine along with Snell & Wilmer are proud to announce the 18th annual 30 Women T...
CXO of the Year 2015 - NOMINATIONS NOW OPEN!Utah Business Event
Jun 25, 2015
NOMINATIONS NOW OPEN_______DEADLINE TO ENTER: April 13, 2015 at 10 a.m. Nomination Forms ...
Community Events View All
Introduction to Human Resource Management 5-day Certificate Program
Mar 31, 2015
Brand new for 2015! Our newly redesigned Introduction to Human Resource Management Certificate P...
LEAD2015.com
Mar 31, 2015
LEAD is a way to hit the Re-Start Button: a two-day leadership conference featuring 22 hand-selec...

info@utahbusiness.com  |  90 South 400 West, Ste 650 Salt Lake City, Utah 84101   |  (801) 568-0114

Advertise with Utah Business

Submit an Event

* indicates required information
* Event Name:
Price (general):
Website (if applicable):
Coordinator's Name:
Coordinator's Email:
Coordinator's Phone:
Venue Name:
Venue Address:
Venue City:
Venue Zip:
Event Capacity:
Date(s):
to
* Event Description:
  Cancel